A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds.
chronic kidney disease
culturally and linguistically diverse background
diabetes
integrated kidney and diabetes model of care
patient activation
Journal
Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
revised:
15
06
2023
received:
10
02
2023
accepted:
18
08
2023
medline:
10
11
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Little is known about the relationship between patients' cultural and linguistic backgrounds and patient activation, especially in people with diabetes and chronic kidney disease (CKD). We examined the association between culturally and linguistically diverse (CALD) background and patient activation and evaluated the impact of a codesigned integrated kidney and diabetes model of care on patient activation by CALD status in people with diabetes and CKD. This longitudinal study recruited adults with diabetes and CKD (Stage 3a or worse) who attended a new diabetes and kidney disease service at a tertiary hospital. All completed the patient activation measure at baseline and after 12 months and had demographic and clinical data collected. Patients from CALD backgrounds included individuals who spoke a language other than English at home, while those from non-CALD backgrounds spoke English only as their primary language. Paired t-tests compared baseline and 12-month patient activation scores by CALD status. Patients from CALD backgrounds had lower activation scores (52.1 ± 17.6) compared to those from non-CALD backgrounds (58.5 ± 14.6) at baseline. Within-group comparisons showed that patient activation scores for patients from CALD backgrounds significantly improved by 7 points from baseline to 12 months follow-up (52.1 ± 17.6-59.4 ± 14.7), and no significant change was observed for those from non-CALD backgrounds (58.5 ± 14.6-58.8 ± 13.6). Among patients with diabetes and CKD, those from CALD backgrounds report worse activation scores. Interventions that support people from CALD backgrounds with comorbid diabetes and CKD, such as the integrated kidney and diabetes model of care, may address racial and ethnic disparities that exist in patient activation and thus improve clinical outcomes. Patients, caregivers and national consumer advocacy organisations (Diabetes Australia and Kidney Health Australia) codesigned a new model of care in partnership with healthcare professionals and researchers. The development of the model of care was informed by focus groups of patients and healthcare professionals and semi-structured interviews of caregivers and healthcare professionals. Patients and caregivers also provided a rigorous evaluation of the new model of care, highlighting its strengths and weaknesses.
Sections du résumé
BACKGROUND
Little is known about the relationship between patients' cultural and linguistic backgrounds and patient activation, especially in people with diabetes and chronic kidney disease (CKD). We examined the association between culturally and linguistically diverse (CALD) background and patient activation and evaluated the impact of a codesigned integrated kidney and diabetes model of care on patient activation by CALD status in people with diabetes and CKD.
METHODS
This longitudinal study recruited adults with diabetes and CKD (Stage 3a or worse) who attended a new diabetes and kidney disease service at a tertiary hospital. All completed the patient activation measure at baseline and after 12 months and had demographic and clinical data collected. Patients from CALD backgrounds included individuals who spoke a language other than English at home, while those from non-CALD backgrounds spoke English only as their primary language. Paired t-tests compared baseline and 12-month patient activation scores by CALD status.
RESULTS
Patients from CALD backgrounds had lower activation scores (52.1 ± 17.6) compared to those from non-CALD backgrounds (58.5 ± 14.6) at baseline. Within-group comparisons showed that patient activation scores for patients from CALD backgrounds significantly improved by 7 points from baseline to 12 months follow-up (52.1 ± 17.6-59.4 ± 14.7), and no significant change was observed for those from non-CALD backgrounds (58.5 ± 14.6-58.8 ± 13.6).
CONCLUSIONS
Among patients with diabetes and CKD, those from CALD backgrounds report worse activation scores. Interventions that support people from CALD backgrounds with comorbid diabetes and CKD, such as the integrated kidney and diabetes model of care, may address racial and ethnic disparities that exist in patient activation and thus improve clinical outcomes.
PATIENT OR PUBLIC CONTRIBUTION
Patients, caregivers and national consumer advocacy organisations (Diabetes Australia and Kidney Health Australia) codesigned a new model of care in partnership with healthcare professionals and researchers. The development of the model of care was informed by focus groups of patients and healthcare professionals and semi-structured interviews of caregivers and healthcare professionals. Patients and caregivers also provided a rigorous evaluation of the new model of care, highlighting its strengths and weaknesses.
Identifiants
pubmed: 37635378
doi: 10.1111/hex.13859
pmc: PMC10632627
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2584-2593Informations de copyright
© 2023 The Authors. Health Expectations published by John Wiley & Sons Ltd.
Références
Patient Educ Couns. 2022 Apr;105(4):821-827
pubmed: 34274165
JAMA Surg. 2021 Jan 1;156(1):e205002
pubmed: 33146682
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
Health Expect. 2017 Dec;20(6):1375-1384
pubmed: 28675539
BMJ Open Diabetes Res Care. 2020 Jan;8(1):
pubmed: 31958294
J Community Health. 2014 Feb;39(1):40-9
pubmed: 23918645
PLoS One. 2019 Jul 15;14(7):e0219685
pubmed: 31306453
Health Lit Res Pract. 2017 Jul;1(3):e128-e135
pubmed: 29806046
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Health Sci Rep. 2022 Jul 20;5(4):e735
pubmed: 35873391
Med Care. 2008 Aug;46(8):795-805
pubmed: 18665059
BMC Public Health. 2022 May 3;22(1):880
pubmed: 35505307
Patient Educ Couns. 2016 Jun;99(6):1033-7
pubmed: 26809936
SAGE Open Med. 2016 Jan 13;4:2050312115625162
pubmed: 26835017
Med Care Res Rev. 2013 Dec;70(6):636-52
pubmed: 23864112
Patient Educ Couns. 2015 May;98(5):545-52
pubmed: 25744281
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
Eur J Cardiovasc Nurs. 2020 Dec;19(8):721-731
pubmed: 32375491
PLoS One. 2022 Aug 10;17(8):e0271661
pubmed: 35947543
Eur J Health Econ. 2020 Nov;21(8):1211-1221
pubmed: 32632820
Nephrology (Carlton). 2018 Aug;23(8):711-717
pubmed: 29405503
J Gen Intern Med. 2019 Sep;34(9):1782-1789
pubmed: 31240605
Med Care Res Rev. 2014 Oct;71(5):472-95
pubmed: 25027408
BMC Health Serv Res. 2016 Oct 18;16(1):582
pubmed: 27756341
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
BMC Fam Pract. 2020 Aug 8;21(1):158
pubmed: 32770944
West J Nurs Res. 2021 Jun;43(6):517-529
pubmed: 33012264
BMC Nephrol. 2017 Feb 28;18(1):80
pubmed: 28245800
J Health Commun. 2016;21(1):67-75
pubmed: 26313690
Am J Public Health. 2015 Dec;105(12):e60-76
pubmed: 26469668
J Gen Intern Med. 2012 May;27(5):520-6
pubmed: 22127797
Med J Aust. 2022 Jun 6;216 Suppl 10:S5-S8
pubmed: 35665937
Health Qual Life Outcomes. 2018 Nov 19;16(1):215
pubmed: 30454062
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203915119
pubmed: 35914161
Int J Environ Res Public Health. 2021 Jan 16;18(2):
pubmed: 33467144
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Health Expect. 2023 Dec;26(6):2584-2593
pubmed: 37635378
BMC Health Serv Res. 2018 May 10;18(1):350
pubmed: 29747651
Cochrane Database Syst Rev. 2015 Mar 03;(3):CD010523
pubmed: 25733495
Am J Manag Care. 2009 Jun;15(6):353-60
pubmed: 19514801
Health Aff (Millwood). 2015 Mar;34(3):431-7
pubmed: 25732493
BMC Geriatr. 2018 Jan 5;18(1):7
pubmed: 29304752
Nephrol Dial Transplant. 2022 Jul 26;37(8):1472-1481
pubmed: 34314493
J Health Care Poor Underserved. 2010 Aug;21(3):796-808
pubmed: 20693726
Medicine (Baltimore). 2021 May 14;100(19):e25929
pubmed: 34106661
BMJ Open. 2017 Oct 22;7(10):e017695
pubmed: 29061622
Health Promot J Austr. 2012 Aug;23(2):84-5
pubmed: 23088482
J Med Internet Res. 2016 Jun 22;18(6):e116
pubmed: 27334418
N Engl J Med. 2012 Mar 1;366(9):777-9
pubmed: 22375966